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Abstract 
During the last two decades the amount of Zn consumed from Zn-
fortified foods and Zn rich dietary supplements have doubled for all 
age groups and the amount of this will further increase over time. 
The effect of long term increasing Zn load in the blood lipid profile 
and tissue minerals status in the body has not been worked out so 
far. In this study, three groups of rats were fed on semi-synthetic 
diet containing 20 mg Zn/kg (control, group-I), 40mg Zn/kg (group-
II) and 80mg Zn /kg (group-III) diet respectively for a period of 180 
days. The results revealed that the gained in body weight increased 
in rats in Zn concentration dependent manner. The blood lipid profile 
displayed a significant rise in serum total lipids, cholesterol, 
triglycerides, LDL-cholesterol, VLDL- cholesterol whereas HDL-
cholesterol showed a reduction in their levels in group-II and III than 
their control counter parts. The tissue metal status showed an 
increase of Zn, Cu, Mg and Mn in the serum, a rise in Zn in liver and 
kidney and fall in Cu, Mg and Mn in kidney and liver. This data 
suggest that excess Zn in diet when fed for longer periods of time 
alter blood lipid metabolisms and tissue minerals status. 
 
Key words: Zn, Cu, Mg, Mn, Zn- supplementation, Blood lipid 
profile, Minerals status 
Introduction 
It is well documented that zinc (Zn) is an essential trace mineral 
which is necessary for health and growth and is particularly 
important for the function and activity of over 200 metalloenzymes 
(Chen et al. 1991, NRC, 1989). Zinc also acts as indirect antioxidants 
via stabilization of cell membranes and the inhibition of free radicals 
production (Bray and Bettger, 1990). Inspite of the fact that Zn is an 
essential micronutrient, there are studies which reported that both 
deficiency and excess of Zn can cause dyslipidemia and impair 
hepatic cholesterol and enhance oxidative stress (Subramanyam and 
Vijaya, 1997). Contradictory evidences and results were reported 
from different studies regarding the effect of Zn supplementation on 
plasma lipids levels both in animals (Allen and Klevay, 1978, Koo 
and Lee, 1989) and humans (Hopper et al.1980, Chandra, 1984, 
Freeland Graves et al. 1982). The majority of human trials studies 
have shown either increase/decreased or unaffected by the 
supplementation of excess Zn in blood cholesterol (AREDS Report, 
2002, Bogden et al. 1988), triglycerides (Gato and Samman , 1995), 
LDL-cholesterol (Chandra, 1984) and HDL- cholesterol level (Black et 
al. 1988).  
Moreover, the association of altered metal status with change in 
blood lipid profiles has been reported by different investigator 
differently. Sugawara, in 1984, found a positive correlation between 
serum cholesterol and serum Cu and Zn concentration.  A positive 
relationship between serum Zn and Zn to Cu ratio with plasma total 
cholesterol and LDL-cholesterol has also been reported (Tully et al. 
1995). The ratios of Zn to Cu appear to affect the level of lipoprotein 
in the blood. High levels of Zn intake have been shown to lower HDL 
- cholesterol levels in blood, raise total and LDL- cholesterol, induce 
platelet aggregation and lead to atherosclerosis in animals (Klevay 
and Hyge 1973). Cu deficiency is associated with atherogenic 
changes in lipid profiles i.e increased LDL – cholesterol and 
decreased HDL- cholesterol which are risk factor for cardiovascular 
diseases (Klevay, 1983). Moreover, evidence is available to suggest 
that there is association between dietary Mg and Mn deficiencies, 
plasma lipid disorders and cardiovascular diseases (Seelig and 
Heggtveit, 1974, Seelig, 1980, Dorothy et al. 2003).  
Even though Zn is an essential micronutrient, the use of Zn 
supplements has been discouraged by some health professional 
because excessive intake of Zn has been reported to induce Cu, Mg, 
and Mn deficiencies due to their antagonistic interactions (Aaseth et 
al. 1998, Couzy et al. 1993, Yadrik et al. 1989). This antagonistic 
interaction is of practical concern because experimental data 
suggested that deficiency these trace minerals impairs enzymes of 
antioxidant system and can produce variety of biochemical and 
physiologic changes and has been implicated in the etiology of 
chronic diseases (Rayssiguier et al. 1993, Thompson et al. 1992). 
During the past two decades, there has been a rise in the 
consumption of higher Zn either from Zn fortified foods as in the 
USA (Arsenault and Brown, 2003), or from vegetables (40mg/kg or 
more in above ground vegetables and 120mg/kg above in the 
underground vegetables) and meat foodstuffs (120 mg Zn/kg) as in 
some States of India (Ram et al, 2005; Singh and Taneja, 2010) 
and this will increase over time. This guided us to investigate the 
real situation of the long term effect of increasing Zn load in 
the blood lipid profile and tissue minerals status of the body. 
Therefore, the supplementation of pharmacological dosage of Zn 
in otherwise Zn adequate diet was investigated with the aim if 
excess Zn in the diet triggers alteration in blood lipid metabolism 
and minerals status in rats which are not genetically 
predisposed to any diseases. The results of the present study are 
given in this communication. 
Material and Methods 
For the present investigations,  a semi-synthetic basal diet rich in fat 
and refined sucrose was preferred over the standard pellet rat diet 
consisting of the natural ingredients to keep the consistency of the 
composition of diet particularly of fat, sucrose and micronutrients 
through out of the experiment and to rule out the possibility of Zn- 
interaction with fibers and phytates (Oberleas and Harland, 1981, 
Turnland et al. 1984) which are known to reduced bioavailability of 
Zn by binding it in digestive tract and may take longer time duration 
of feeding to manifest the impact excessive Zn in diet. Accordingly, 
isocaloric semi-synthetic basal diet for the rats was prepared 
following modified Orgebin – crist et al. (1971). It contained (g/100g 
of diet). 
The basal diet was further divided into 2 parts: control diet 
consisting of basal diet containing 20 mg Zn/kg diet (per-se) for 
Group- I and Zn-supplement-diet-I containing 40 mg Zn/kg diet for 
Group – II and Zn supplemented-diet-II containing 80mg Zn/kg diet 
for Group-III by accordingly increasing ZnSO4.7H2O in basal diet. For 
each diet, the mineral & water-soluble vitamins were ground in 
sucrose and fat-soluble vitamins were dissolved in corn oil. Agar, 
which served as a binder and was dissolved in 25 ml of triple 
distilled, deionised warm water (60°C). On cooling to 40°C, the 
contents of each diet were thoroughly mixed in agar solution in 
separate containers. The dough so formed was put in petridishes 
and solidified in refrigerator. The solidified diet was cut into small 
pieces of 2 × 2 × 2 cm size and stored in the container at the 
temperature >- 4°C.  
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Table 1. Composition of Basal Diet 
 
 Diet Components  g/100g *Vitamin Mixture (mg/ kg) **Mineral Mixture (g/kg) 
Casein 30 Ascorbic acid – 500 CaH2PO4 - 25.3 
Agar 2.0 Biotin – 4 CoCl3 – 0.04 
Corn oil  5 Calcium- D- pentothenate – 320 CuCl2 – 0.10 
Cellulose  8 Choline chloride – 2500 FeSO4 7H2O - 0.60 
Sucrose  51.0 Folic acid – 10 Mn SO4.5H2 O - 0.31 
*Vitamin mixture 0.50 Inositol – 1000 Mg SO4 .H2O - 4.05 
**Mineral mixture 3.50 Retinol - 0.31 NaF - 0.088 
Total diet 100 Pyridoxine HCl – 80 Kl - 0.004 
  Riboflavin -120 Na2CO3 -1.15 
  Ergacalciferol - 0.0031 KCL – 3.430 
  Thiamin HCl – 200 Zn SO4 .7H2O - 0.088 
  α-Tocopherol  acetate (E) – 60  
  Cyanocobalamin - 0.40  
  Nicotinic acid – 300  
 
Experimental Design 
Male wistar rats (30), aged 6 weeks, weighing 60-70g were 
procured from Central Animal House, Panjab University, Chandigarh. 
They were maintained in plastic cages with stainless steel top grill at 
room temperature (25° - 28°C) with 10:14 hr L: D cycles of 70-80% 
RH as per guide lines of Institutional Animals Ethics Committee and 
in accordance with the internationally accepted principles for 
laboratory animal use and care. 
They were fed on standard pellet rat feed for one week to 
acclimatize. Thereafter, the rats were divided into 3 groups – I, II 
and III and in such a way that their mean initial body weights 
remained almost similar in each group. The animals were fed on 
their respective diets ad libitium and triple distilled deionised water 
was made freely available to them for 180 days. The body weights 
were recorded at the beginning of the dietary treatment and 
thereafter every week. After the end of the dietary treatment of 180 
days, the male rats of each group were sacrificed using diethyl ether 
as anaesthesia. 
The blood samples were collected by puncturing the heart and blood 
serum was prepared by centrifuging blood at 2500 rpm for 15 
minutes. The freshly prepared serum was analyzed for cholesterol 
(Roeschlau et al, 1974, Allain et al. 1974), triglycerides (McGowan et 
al. 1983, Fossati and Prencipe, 1982), HDL-cholesterol (Burstein et 
al. 1970) (all by using commercially available kits- Reckon Diagnostic 
Pvt, Ltd, Baroda, India and ERBA diagnostic Mannheim GmbH, 
Mannheim, Germany, supplied through Transasia Bio- Medicals LTD, 
Daman) and total lipids (Frings and Dunn, 1971). The LDL and 
VLDL-cholesterol was calculated by Friedewald’s equation 
(Friedewald et al. 1972).  
Zn, Cu, Mg and Mn were estimated on atomic absorption 
spectrophotometer (Electronic Corporation of India Limited, 
Hyderabad- AAS 4139) using hollow cathode lamps (213.9nm, 
324.8nm, 285.2nm and 279.5nm for Zn, Cu, Mg and Mn 
respectively). Samples of serum, liver and kidney are digested 
separately in 3:1 v/v nitric acid and perchloric acid on a sand bath 
until a white ash formed. The ash was dissolved in 6 ml of 10mM 
HNO3 and filtered through ash free filter paper before analysis. 
Standards of Zn, Cu, Mg and Mn from Sigma Chemical Co., USA 
were prepared by dilution in triple distilled deionised water (TDW). 
The results were subjected to statistical analysis applying one way 
ANOVA.  
Results and Discussion 
The data of the study revealed that the body weight of the rats 
increased with increase in Zn concentration in diet during the first 
150 days of dietary treatment in the three groups of rats and 
thereafter it fell in group-II and III during the next 30 days with 
respect to their weight at 150 days than their control counterparts at 
day 180 of the experiment. The data revealed that Zn is highly 
potent nutrient which initially promotes gain in body weight in 
concentration dependent manner and its prolong supplementation 
results in reduction of body weight (Table 2).  
 
Table 2: Month wise body weight of male rats of Group-I [( fed on basal diet( Control)], Group-II ( fed on Zn- supplemented- diet- I) and Group- III( fed on Zn supplemented diet- 
II) during 180 days of dietary treatment.[Values are mean ± SE of 10 observation each] 
 
Time duration(in days) Group-I (Control) Group-II Group-III 
0 68.0 ± 0.68 67.0 ± 0.67 67.2 ± 0.79 
30 162.15 ± 1.12 192.25 ± 1.13a 231.46 ± 1.67 a 
60 199.17 ± 1.53 271.67 ± 1.67 a 297.25 ± 1.14 a 
90 261.36 ± 1.97 318.33 ± 1.70 a 363.43 ± 0.860 a 
120 280.50 ± 1.70 346.14 ± 1.60 a 384.55 ± 1.39 a 
150 320.67 ± 1.13 359.57 ± 1.78 a 411.65 ± 1.67 a 
180 371.35 ± 0.82 331.83 ± 1.10 a 371.67 ± 1.67 a 
                        Units: gram; P values: a < 0.001(values of group- II and group-III were compared with group-I). 
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This is in conformity with the reports of the previous studies (Pomp 
et al. 1996, Chen et al. 1996, Taneja and Mandal, 2006) wherein Zn 
more than 20mg/kg diet (control) and not exceeding 100mg/kg diet 
fed to rats for a period of extending 4 to 6 weeks resulting in a 
significant gain in body weight than the control has been recorded. 
Investigatory studies on laboratory animals also provides evidences 
that the anabolic effects of Zn results from the higher absorption of 
nutrients i.e amino acids (Moran and Lyerly, 1985 ), fatty acids ( Koo 
and Turk, 1977) and glucose ( Taneja and Arya, 1992 ) in addition 
to activation protein and nucleic acid syntheses. A positive 
correlation between hair Zn and body weight or BMI has been seen 
to exist (Taneja et al.1996, Taneja and Mahajan. 1999). 
 
Table 3: Blood profile of male rats of  Group-I [( fed on basal diet( Control)], Group-II ( fed on Zn- supplemented- diet- I) and Group- III( fed on Zn supplemented diet- II) during 
180 days of dietary treatment.[Values are mean ± SE of 10 observation each] 
 
 
 
 
 
 
 
 
 
 
 
                     Units: *: mg/dl; P values: a <0.001(values of group- II and group-III were compared with group-I). 
 
The blood profile of treated rats revealed significant rise of total 
lipids, cholesterol, triglycerides, VLDL – cholesterol and LDL- 
cholesterol and decreased HDL-cholesterol after 180 days of Zn 
supplementation in group-II and group-III as compared to the 
control group-I (Table-3). These observations are consistent with 
previous reports from both in human and animal studies where 
supplementation of Zn increased blood cholesterol (both LDL and 
VLDL-c) and decreased in HDL- cholesterol level (Subramanyam and 
Vijaya, 1997, Chandra, 1984, Black et al, 1988, Hopper et al. 1980). 
This alteration in serum lipoproteins profiles in the Zn treated group-
II and III in the present investigations may be resulted from 
deficiency of Cu, Mg and Mn in the tissues as a consequence of high 
Zn supplementation. The assessment of the metal status in the 
present study showed that Cu, Mg and Mn were approximately up to 
30% less in group-II and up to 50% less in group- III rats both in 
liver and kidney indicating the induction of the Cu, Mg and Mn 
deficiencies or rise in ratio of Zn to Cu/ Mg/Mn in the tissues. This 
rise of serum total lipids, cholesterol, triglycerides, VLDL and LDL- 
cholesterol an fall in HDL- cholesterol after 180 days of treatment in 
group-II and III rats coincide very well with degree of fall of Cu 
concentration in these tissue, inspite of the fact that blood serum 
has higher Cu concentration than the control rat. Cu deficiency 
induced hypercholesterolemia has been demonstrated in animals 
and humans (Bureau et al. 1998, Nielsen and Milne, 1992). The 
plasma cholesterol increase by increasing dietary Zn at all levels Cu 
suggests that dietary Zn seems to suppress the plasma cholesterol 
lowering effect of dietary Cu (Klevay, 1975, Lata and Mehta, 1989). 
Cholesterol appeared to clear from the liver to blood plasma faster 
in the copper deficient rats than the control (Allen et al. 1982, Shao 
and Lei, 1980), as a result of the increased in the activity of liver 
enzyme, 3-hydroxy-3 methylglutamate coenzyme A reductase 
(Yount et al. 1990, Koo et al. 1993), the rate limiting enzyme in 
cholesterol biosynthesis and decrease in the lipoprotein lipase, 
hepatic lipase and lecithin cholesterol acyltransferase (ICAT) activity 
(Lau and Klevay, 1981).  
Experimental Mg deficiency has also been shown to increase 
triglycerides, cholesterol, VLDL, LDL rich lipoproteins and reduced 
HDL-cholesterol (Rayssiguier and Gueux, 1986, Gueux et al. 1991), 
almost similar to Cu deficiency. In Mg deficient animals, 
hypertriglyceridemia could have arisen as a consequence of 
increased synthesis of triglycerides in the liver, decreased removal of 
lipid from the blood or combination of both. An increased in the 
HDL–cholesterol concentration is closely associated with triglyceride 
metabolism and defective triglyceride removal from the plasma 
compartment might explain low HDL-cholesterol level as found in 
the present investigations. Kawano et al. 1987 also observed 
reduced HDL- cholesterol, HDL protein and HDL apo-E levels with 
Mn deficiency. Because HDL particles carry a major portion of 
plasma cholesterol in the rat, these changes could affect cholesterol 
metabolism in Zn treated groups. One more possible mechanism for 
the alteration of lipid levels in Mn-deficient animals is that Mn 
deficiency resulted in increased lipid peroxidation of the endoplasmic 
reticulum, which is the site of lipoprotein synthesis. Bell and Hurley, 
1973, observed swollen and irregular endoplasmic reticulum in 
tissues of Mn- deficient mice. This suggests that the observed rise of 
in level of cholesterol, triglycerides, VLDL- cholesterol and LDL- 
cholesterol and reduction in HDL- cholesterol in the group-II and III 
rats in the present investigations resulted due to Cu deficiency 
couple with Mg and Mn deficiency in tissues caused by excessive Zn 
in diet. Such lipid metabolism disorders have become common and 
important problems in clinical medicine. Interest in lipid disorder 
arises from their close relationship to vascular diseases, a major 
problem of western and currently in developing countries. 
Prospective data have been shown that the risk of coronary heart 
diseases is related to the serum cholesterol and triglyceride levels 
(Morrison and John, 2009, Larsa and Böttiger, 2003). The 
contribution of the serum total cholesterol to risk has also been 
found to be determined by its partitioned in the various lipoprotein 
fractions. A relatively large amount of cholesterol in the LDL- 
lipoprotein faction is atherogenic whereas that in the HDL fractions 
appears protective (Gordon et al. 1977). 
The results of the blood lipid profile in the present study were 
consistent with deterioration of the metal status in the group –II and 
III rats which in turn led to an increase of the cholesterol, 
triglycerides, VLDL-c, LDL-c and decrease in HDL-c in their 
respective groups. The element analysis in the three groups of rats 
revealed that serum Zn, Cu, Mg and Mn increased significantly  in 
group-II and III compared to those control rats in group-I. 
Moreover, Zn in liver and kidney was found to be significantly higher 
whereas Cu, Mg and Mn were significantly lowered in group-II and 
III compared to those control counterpart (Table 4). The increase of 
these elements were more in serum of  group-III than in group-II 
inspite of the fact that only the amount of Zn on the diet has been 
increased while Cu, Mg and Mn were adequate and were in equal 
amount to the diet of group-I. The metal status in the blood plasma 
at a given time represents a total of bound, exchangeable and 
catabolic components of metals and therefore could lead to 
confusing results and predictions. The concentration of metal in 
tissues are better indicator of their status in the body than the blood 
plasma in assessing metal deficiencies or excess since their level are 
maintained by a dynamic equilibrium between tissue metals and 
exchangeable metal components of blood plasma. The present data 
of micro and macro elements indicated that Zn when in excess, even 
in pharmacological doses in diet, over a period of time replaces Cu, 
Parameters Group-I(Control) Group-II Group-III 
Total Lipids* 202.50 ±2.14 248.17 ± 1.78 a 310.33 ± 2.86 a 
Cholesterol* 61.67 ± 2.17 82.0 ± 1.02 a 115.0 ± 1.86 a 
Triglycerides* 63.67 ± 1.56  104.83 ± 1.76 a 121.67 ± 2.67 a 
VLDL- Cholesterol* 12.7 ± 0.320 20.97 ± 0.360 a 24.3 ± 0.340 a 
HDL-Cholesterol* 20.67 ± 1.12 12.67 ± 0.710 a 8.83 ± 0.410 a 
LDL- Cholesterol* 28.27 ± 1.35 48.37 ± 0.760 a 81.83 ± 1.94 a 
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Mg and Mn leading to their leaching in the blood and excretion in 
the urine even if these metals are adequate in diet. This leaching of 
Cu, Mg and Mn from the soft tissues in to the blood resulted in their 
deficiencies in the tissue as observed in liver and kidney of group-II 
and III rats.  
 
Table-4: Mean Zinc(Zn), Copper(Cu), Magnesium(Mg) and Manganese (Mn) concentration in the serum, liver and kidney of male rats of  Group-I [( fed on basal diet (Control)], 
Group-II ( fed on Zn- supplemented- diet- I) and Group- III( fed on Zn supplemented diet- II) during 180 days of dietary treatment.[Values are mean ± SE of 10 observation each] 
 
Parameters Group-I(Control) Group- II Group-III 
Serum Zn* 0.57  ±  0.05 1.70  ±  0.02 a 1.90  ±  0.05 a 
Serum Cu* 0.95  ±  0.04 2.35  ±  0.05 a 3.23  ±  0.14 a 
Serum Mg* 1.56  ±  0,08 1.70   ± 0.06 a 1.96    ± 0.04 a 
Serum Mn* 0.21  ±  0.05 0.67  ±  0.05 a 1.01  ±  0.06 a 
Liver Zn@ 32.7 ± 0.88 44.1 ± 0.84 a 57.0 ± 0.65 a 
Liver Cu@ 60.3 ± 0.68 43.9 ± 1.13 a 30.3 ± 0.77 a 
Liver Mg@ 61.0 ± 1.03 48.0 ± 0.49 a 34.0 ± 0.90 a 
Liver Mn@ 47.80 ± 0.59 36.40 ± 0.65 a 30.90 ± 0.66 a 
Kidney Zn@ 35.4 ± 0.54 42.7 ± 0.69 a 55.5 ± 1.52 a 
Kidney Cu@ 53.5 ± 0.74 46.50 ± 0.68 a 38.10 ± 0.63 a 
Kidney Mg@ 54.50 ± 0.84 45.90 ± 0.54 a 35.20 ± 0.76 a 
Kidney Mn@ 42.80 ± 1.87 37.90 ± 0.94 a 28.20 ± 0.62 a 
                 Units: *: mg/dl; @: µg/g tissue weight; P values: a < 0.001(values of group- II and group-III were compared with group-I). 
 
However, in the present study urinary Zn, Cu, Mg and Mn level was 
not assessed because only trace amounts are found in the urine and 
urinary loss of metal is only small fraction of their turnover, thereby 
limiting its use as a sensitive indicator of metal status. The observed 
increase of Zn level in liver and kidney in group –II and III rats than 
their control group-I may be attributed to the overexpression of Zn 
metallotheionein gene during treatment period due to high and 
prolong Zn intake. As a result of this they absorbed and retained 
greater amount of Zn than their control counterpart leading to 
deficiencies of Cu, Mg and Mn due to their interactions (Irato et al. 
1996; Nielsen and Milne, 2004). 
The results of the present study thus provide strong evidence that 
excessive Zn in diet even in pharmacological doses alter blood lipid 
metabolism and deteriorated mineral status of the body. These 
findings are particularly significant for the people of some States of 
India where the foodstuffs are overloaded with Zn (Singh and 
Taneja, 2010, Ram et al. 2005). The rising prevalence of 
cardiovascular related diseases even in the young age population 
during the past two decades may not be essentially due to change in 
lifestyle but also may be associated with excessive intake of Zn from 
Zn rich foods which in turn may alter trace minerals and lipoproteins 
metabolism of the body up to a level enough to manifest as 
diseases. Thus, there appear to be several potential adverse 
consequences of such pharmacological doses of Zn particularly when 
such intakes are continued for a prolonged period. 
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